Alzheimer's Disease Antibody Patent Insufficient - Lilly v JAI By Darren Smyth on Wednesday, June 26, 2013 Alzheimer's Disease antibody eli lilly insufficiency inventive step Janssen Alzheimer Immunotherapy novelty solanezumab +